Nutratopic Pro-AMP Facial Cream Active protection that blends with the skin

Nutratopic Pro-AMP Crema facial

A unique facial cream for exposed and fragile areas

Relieves itchiness and increases the skin’s defenses. Its unique DMS formula with lamellar structure is rapidly absorbed by the skin. One of the most exposed, fragile and vulnerable areas in a child with atopy.

Pro-AMP Effect

Pro-AMP effect. The importance of good prevention

In the most fragile area, Nutratopic PRO-AMP Facial Cream provides active protection that is key for keeping atopy under control. It strengthens the skin’s innate immune system, increasing the production of AMPs, with their powerful antimicrobial and antiviral properties. They also inhibit bacterial adhesion thanks to Rhamnosoft.

When a picture is worth a thousand words

Deeply hydrates and fights the signs of facial atopic dermatitis. 83% of patients treated experienced a significant reduction of associated symptoms.


Before Nutratopic Pro-AMP Facial Cream


After Nutratopic Pro-AMP Facial Cream

Helps to reduce visible symptoms in just 28 days

Nutratopic Pro-AMP Facial Cream contains L-isoleucine and active ingredients, and has a lamellar structure allowing it to blend with the skin. Its daily use provides deep hydration and helps to reduce itchiness and inflammation. It reduces the main visible signs of facial atopic dermatitis in less than one month: itchiness, dryness, flaking, erythema and skin oedema.

Its efficacy has been tested in atopic children, demonstrating good skin tolerance.

Evolución del Eczema Severity Score

Nutratopic Pro-AMP facial reduces the ESS by 85% vs 50% with a standard emollient cream

The ESS Eczema Severity Score measures the severity of an outbreak, according to erythema, thickness, itching and lichenification of the skin. Evaluation from 0 (none) to 3 (severe).

Study characteristics N=107, mean age 5-6 years, Randomised, Multicentre, blind. * Study published in MINERVA PEDIATR 2014, VOL. 66; M. PUVIANI (Unit of Dermatology and Surgical Dermatology Sassuolo Hospital, Sassuolo, Modena, Italy), F. AGOSTINIS (Center of Dermatology, Bergamo, Italy), M. MILANI (Direzione Medica ISDIN Italia)..